📑 Extensive Product Profile: Understanding Buselin 7ML Injection

Buselin 7ML Injection contains Buserelin Acetate, an advanced, highly potent synthetic peptide analogue of natural gonadotropin-releasing hormone (GnRH / LHRH). Manufactured to strict international quality benchmarks by premium pharmaceutical formulation lines in India, it is extensively prescribed by global oncologists and reproductive specialists to manage hormone-dependent malignancies and gynecological disorders.

1. Clinical Indications & Usage

Buselin 7ML is a multidose injectable targeted therapy globally indicated for:

• Advanced Prostate Carcinoma: Used as a primary palliative intervention for hormone-dependent advanced prostate cancer. It is highly effective at reducing testosterone to castrate levels, slowing the proliferation of androgen-dependent tumor cells.

• Endometriosis: Deployed to down-regulate pituitary tissue, suppressing ovarian estrogen production to reduce endometrial lesions and associated chronic pelvic pain.

• Uterine Fibroids (Leiomyomata): Prescribed to shrink the volume of uterine fibroids prior to planned surgical excision or as a conservative management pathway to reduce heavy menstrual bleeding.

• Assisted Reproductive Technology (ART): Utilized in specialized IVF protocols for pituitary desensitization (down-regulation) to prevent premature luteinizing hormone (LH) surges before controlled ovarian hyperstimulation.

2. Mechanism of Action: How Buselin Works

Buselin functions through a highly specific, biphasic endocrinological pathway:

• Initial Pituitary Stimulation: Upon early administration, Buserelin binds directly to GnRH receptors in the anterior pituitary gland, causing a temporary surge in the release of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) (the "flare" effect).

• Receptor Down-Regulation: Continuous exposure to this potent synthetic analogue causes the pituitary GnRH receptors to become heavily desensitized and down-regulated.

• Hormonal Suppression (Chemical Castration): Within a few weeks, the pituitary gland completely ceases the production of LH and FSH. This blocks the signals to the gonads, leading to a profound suppression of sex hormones—reducing testosterone in men and estradiol in women to post-menopausal or castrate levels.

3. Administration and Dosing Guide

• Administration Route: Buselin 7ML is a multidose liquid solution primarily intended for Subcutaneous (SC) injection. It must be administered using sterile, micro-dose syringes to ensure absolute precision.

• Standard Schedule (Prostate Oncology Frontline): Clinical protocols typically initiate treatment with subcutaneous infusions of 500 micrograms (mcg) injected every 8 hours for the first 7 days to stabilize receptor binding.

• Maintenance Titration: From Day 8 onward, the patient is transitioned to a continuous maintenance dosage framework as directed by the treating oncologist (often via intranasal spray or fixed-interval maintenance injections) based on ongoing serum testosterone or estradiol monitoring.

⚠️ Safety, Side Effects, and Monitoring

Buselin 7ML is a highly potent hormonal agent requiring strict clinical oversight:

• Tumor Flare Manifestations: During the first week of therapy, the temporary surge in testosterone can cause a transient worsening of prostate cancer symptoms. Patients with spinal metastases or urinary tract obstruction must be closely monitored; concurrent anti-androgen therapy is often implemented to prevent complications.

• Bone Density Depletion: Long-term estrogen suppression in women can cause bone mineral density loss. Treatment courses for benign gynecological conditions are typically restricted to 6 months unless paired with add-back therapy.

• Cardiovascular Changes: May cause changes in blood pressure, altered lipid profiles, and an increased risk of glucose intolerance. Regular metabolic check-ups are recommended.

• Common Side Effects: Hot flashes, increased sweating, headaches, mood alterations, sleep disturbances, injection site irritation, libido changes, and transient muscle or joint pain.

📦 Storage and Handling Specifications

• Storage Temperature: Store unopened Buselin 7ML vials consistently between 2°C to 8°C (36°F to 46°F) in a secure medical refrigerator. Do not freeze.

• In-Use Stability: Once the multidose vial is punctured under sterile conditions, it can typically be stored below 25°C (77°F) for a restricted timeframe (usually up to 28 days), depending on exact batch directions.

• Light Safeguards: Keep the vial enclosed in its original outer carton to completely protect the solution from direct UV light degradation.

📄 Regulatory and Compliance Documentation

PRIMECARE IMPEX simplifies international customs pathways and institutional sourcing requirements by accompanying every shipment with an audit-ready compliance dossier:

• Authentic Certificate of Analysis (COA) confirming chemical purity parameters.

• Verified Batch Origin Ledger and commercial traceability paperwork

• GMP compliant manufacturing credentials.

💡 Why Choose PRIMECARE IMPEX?

Sourcing your institutional pharmaceuticals through PRIMECARE IMPEX guarantees a highly secure, verified supply chain setup:

• Full Traceability

• Regulatory Alignment

• Secure Bulk Supply